Biotech & Pharma
Founded on January 13, 2025, QNTLO is a clinical biostatistics consultancy company.
We specialize in providing comprehensive biostatistical and statistical programming services for Phase I and Phase II clinical trials. Our primary objective is to assist clients in selecting the most appropriate dose for their Phase III studies. By offering integrated support during the early stages of clinical development, we enable clients to make data-driven decisions that optimize efficacy and safety outcomes, increasing their likelihood of performing successful phase 3 clinical trials.
We offer end-to-end support, from study design through data analysis, ensuring all early-phase activities are aligned with the goal of optimal dose selection.
Established by Juan Vicente Torres, a statistician with over 20 years of experience in clinical research, the company embodies a wealth of expertise and a deep understanding of the industry’s complexities.
Our vision is to operate as a niche clinical services company that prioritizes quality over quantity. By intentionally maintaining a small team, we ensure that each project receives meticulous attention and that our clients benefit from direct access to our experts. This approach fosters an environment where communication is seamless, teams are fully integrated, and everyone is intimately aware of ongoing projects and company objectives.
QNTILO – Clinical biostatistics consultancy company.
Address: Parc Bit, Galileo Galilei, 2. 07121 Palma, Spain.
E-mail: jvt@qntlo.com